Меню
Идёт набор NCT04332692

Acute Heart Failure - COngestion Discharge Evaluation

Без фазы С лечением Acute Heart Failure

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Clinical examination centered on congestion, Cardiac, pulmonary, peritoneal, jugular, renal Doppler ultrasounds and liver elastography, Blood sample retrieved for biological assessment and biobanking, Telephone follow-up.
Кому может быть актуально
Состояния в реестре: Acute Heart Failure. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Франция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Acute Heart Failure - COngestion Discharge Evaluation. Évaluation de la Congestion à la Sortie d'Hospitalisation Pour Insuffisance Cardiaque aiguë.

Обзор

Acute heart failure (AHF) is a major public health problem, associated with a 40% risk of death or re-hospitalisation at 3 months. This risk is significantly increased by insufficient decongestion at the end of hospitalisation for AHF assessed by a standardised clinical score, a natriuretic peptide dosage or by cardiac and pulmonary ultrasound . Adapting treatment according to lung congestion assessed by implantable devices (not reimbursed in France) improves the prognosis. However, due to the lack of a standardised congestion assessment, therapeutic adaptation in acute heart failure is currently empirical. The best multimodality approach to congestion evaluation is uncertain.

Вмешательства

  • Процедура Clinical examination centered on congestion
    Clinical examination centered on congestion (ASCEND, NYHA and Ambrosy Score) will be performed before discharge from hospital
  • Процедура Cardiac, pulmonary, peritoneal, jugular, renal Doppler ultrasounds and liver elastography
    Cardiac, pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography will be performed before discharge from hospital
  • Процедура Blood sample retrieved for biological assessment and biobanking
    Blood sample retrieved for biological assessment and biobanking will be performed before discharge from hospital
  • Процедура Telephone follow-up
    Telephone follow-up will be performed 3, 12 and 24 months after discharge from hospital
  • Поведенческое Kansas City Cardiomyopathy Questionnaire (KCCQ)
    Questionnaire centered on patient's quality of life at discharge and 3, 12 and 24 months after discharge

Первичные конечные точки

  • Rate of all-cause death [Срок оценки: 3 months after hospital discharge]
  • Rate of re-hospitalisation for acute heart failure [Срок оценки: 3 months after hospital discharge]
  • Rate of day-hospital or in-home IV diuretics injection for acute HF [Срок оценки: 3 months after hospital discharge]
Вторичные конечные точки (12)
  • Rate of all-cause death [Срок оценки: 3, 12 and 24 months after hospital discharge]
  • Rate of re-hospitalisation for acute heart failure [Срок оценки: 3,12 and 24 months after hospital discharge]
  • Rate of day-hospital or in-home IV diuretics injection for acute HF [Срок оценки: 3,12 and 24 months after hospital discharge]
  • Rate of all-cause death [Срок оценки: 12 and 24 months after hospital discharge]
  • Rate of re-hospitalisation for acute heart failure [Срок оценки: 12 and 24 months after hospital discharge]
  • Rate of day-hospital or in-home IV diuretics injection for acute HF [Срок оценки: 12 and 24 months after hospital discharge.]
  • Rate of all-cause death [Срок оценки: 3, 12 and 24 months after hospital discharge.]
  • Rate of hospitalization for acute heart failure [Срок оценки: 3, 12 and 24 months after hospital discharge.]
  • Rate of day-hospital or in-home IV diuretics injection for acute HF [Срок оценки: 3, 12 and 24 months after hospital discharge.]
  • NYHA (New York Heart Association) class measured [Срок оценки: 3, 12 and 24 months after hospital discharge]
  • Natriuretic peptides [Срок оценки: within 24 months after hospital discharge.]
  • Renal function assessed by glomerular filtration rate [Срок оценки: within 24 months after hospital discharge.]

Критерии участия

Критерии включения

  • Patients hospitalised for acute heart failure.
  • Patients considered clinically discharging from hospitalisation for acute heart failure.
  • Age ≥18 years
  • Patients having received complete information regarding the study design and having signed their informed consent form.
  • Patient affiliated to or beneficiary of a social security scheme.

Критерии исключения

  • Comorbidity for which the life expectancy is ≤ 3 months
  • Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular filtration rate <15 ml/min/m2 at inclusion.
  • History of lobectomy or pneumonectomy lung surgery
  • Severe pulmonary or pleural pathology preventing reliable acquisition of lung ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc.
  • Pregnant woman, parturient or nursing mother
  • Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice)
  • Adult person who is unable to give consent
  • Person deprived of liberty by a judicial or administrative decision,
  • Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of the Public Health Code.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Диагностика

Центры проведения

Франция · 1 центр
  • CHRU de Nancy — Vandœuvre-lès-Nancy

Идентификаторы

NCT: NCT04332692 · 2019-A03311-56

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗